- Home
- SDST vs RNXT Comparison
SDST vs RNXT Comparison
Compare SDST & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDST
- RNXT
- Stock Information
- Founded
- SDST 2022
- RNXT 2012
- Country
- SDST United States
- RNXT United States
- Employees
- SDST N/A
- RNXT N/A
- Industry
- SDST Blank Checks
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- SDST Finance
- RNXT Health Care
- Exchange
- SDST Nasdaq
- RNXT Nasdaq
- Market Cap
- SDST 44.9M
- RNXT 40.7M
- IPO Year
- SDST N/A
- RNXT 2021
- Fundamental
- Price
- SDST $5.31
- RNXT $1.12
- Analyst Decision
- SDST Buy
- RNXT Strong Buy
- Analyst Count
- SDST 2
- RNXT 2
- Target Price
- SDST $17.00
- RNXT $7.50
- AVG Volume (30 Days)
- SDST 690.2K
- RNXT 679.7K
- Earning Date
- SDST 11-12-2025
- RNXT 11-12-2025
- Dividend Yield
- SDST N/A
- RNXT N/A
- EPS Growth
- SDST N/A
- RNXT N/A
- EPS
- SDST N/A
- RNXT N/A
- Revenue
- SDST N/A
- RNXT $662,000.00
- Revenue This Year
- SDST N/A
- RNXT $2,895.35
- Revenue Next Year
- SDST N/A
- RNXT $313.04
- P/E Ratio
- SDST N/A
- RNXT N/A
- Revenue Growth
- SDST N/A
- RNXT N/A
- 52 Week Low
- SDST $1.43
- RNXT $0.75
- 52 Week High
- SDST $83.00
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- SDST 63.49
- RNXT 45.47
- Support Level
- SDST $4.76
- RNXT $1.06
- Resistance Level
- SDST $7.67
- RNXT $1.15
- Average True Range (ATR)
- SDST 0.77
- RNXT 0.11
- MACD
- SDST 0.12
- RNXT -0.01
- Stochastic Oscillator
- SDST 48.28
- RNXT 20.55
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.